Aug 10, 2021 05:39 PM (GMT+8) · EqualOcean
Puli pharmaceutical announced that Anhui Puli Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui Puli"), a wholly-owned subsidiary of the company, recently received the drug production license issued by Anhui drug administration. Production scope: API; Valid until: August 2, 2026.